Get the Stockscreener App
276.39
2.24%
-6.34
After Hours:
277.29
0.90
+0.33%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $276.39, with a volume of 2.13M.
It is down -2.24% in the last 24 hours and down -3.01% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$282.73
Open:
$281.04
24h Volume:
2.13M
Relative Volume:
0.96
Market Cap:
$148.80B
Revenue:
$34.76B
Net Income/Loss:
$6.62B
P/E Ratio:
22.60
EPS:
12.23
Net Cash Flow:
$10.61B
1W Performance:
-2.56%
1M Performance:
-3.01%
6M Performance:
-11.56%
1Y Performance:
-16.26%
1-Day Range:
$276.07
$282.94
1-Week Range:
$275.16
$282.94
52-Week Range:
$253.30
$339.17
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
276.39 | 149.94B | 34.76B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
755.39 | 676.48B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.06 | 423.36B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
218.34 | 373.87B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
124.12 | 244.98B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
82.81 | 209.89B | 63.43B | 16.42B | 14.72B | 6.49 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Mkt Perform |
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
2,300 Shares in Amgen Inc. $AMGN Acquired by CTC Alternative Strategies Ltd. - MarketBeat
Kestra Investment Management LLC Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Ascent Group LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Meiji Yasuda Life Insurance Co - MarketBeat
First Dallas Securities Inc. Has $1.97 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Signature Estate & Investment Advisors LLC Purchases 1,872 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Ashton Thomas Private Wealth LLC - MarketBeat
Canada Post Corp Registered Pension Plan Acquires New Shares in Amgen Inc. $AMGN - MarketBeat
Fred Alger Management LLC Grows Stake in Amgen Inc. $AMGN - MarketBeat
Great Lakes Advisors LLC Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
Coppell Advisory Solutions LLC Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
AQR Capital Management LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
Tamar Securities LLC Has $20.45 Million Holdings in Amgen Inc. $AMGN - MarketBeat
USS Investment Management Ltd Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen | Talk of Alabama | 9.12.2025 - WBMA
Plato Investment Management Ltd Sells 3,091 Shares of Amgen Inc. $AMGN - MarketBeat
1,863 Shares in Amgen Inc. $AMGN Bought by Ransom Advisory Ltd - MarketBeat
5,416 Shares in Amgen Inc. $AMGN Acquired by SCS Capital Management LLC - MarketBeat
Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com
Talon Private Wealth LLC Invests $856,000 in Amgen Inc. $AMGN - MarketBeat
NewEdge Advisors LLC Purchases 6,685 Shares of Amgen Inc. $AMGN - MarketBeat
Understanding the Setup: (AMGN) and Scalable Risk - news.stocktradersdaily.com
UniSuper Management Pty Ltd Has $27.97 Million Position in Amgen Inc. $AMGN - MarketBeat
(AMGN) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Amgen Inc. $AMGN Shares Bought by New England Asset Management Inc. - MarketBeat
Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab - Yahoo Finance
(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback - Benzinga
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $1.45 Billion Position in Amgen Inc. $AMGN - MarketBeat
(AMGN) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Zurich Insurance Group Ltd FI Grows Holdings in Amgen Inc. $AMGN - MarketBeat
The Escalator: Amgen, Havas Health Network, Arena BioWorks and more - Medical Marketing and Media
Logan Capital Management Inc. Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Voleon Capital Management LP - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 36,551 Shares of Amgen Inc. $AMGN - MarketBeat
Eventide Asset Management LLC Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Nissay Asset Management Corp Japan ADV - MarketBeat
Paying Tribute to One of Amgen’s Own on 9/11 - Amgen
Amgen Inc. $AMGN Shares Sold by Curi RMB Capital LLC - MarketBeat
The Technical Signals Behind (AMGN) That Institutions Follow - news.stocktradersdaily.com
Jacobs Levy Equity Management Inc. Buys New Position in Amgen Inc. $AMGN - MarketBeat
Beyond MariTide: Amgen Makes Portfolio Play Amid Scrutiny of Obesity Prospect - BioSpace
Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study - simplywall.st
Kriya, Odyssey secure ‘megarounds’; Amgen boosts R&D leadership - BioPharma Dive
Shannon Turley now part of Amgen Research’s bold new era - The Pharma Letter
How (AMGN) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.81%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):